Vumon

Active Ingredient(s): Teniposide
FDA Approved: * July 14, 1992
Pharm Company: * BRISTOL MYERS SQUIBB
Category: Cancer

Teniposide (trade name Vumon) is a chemotherapeutic medication[1] used in the treatment of childhood acute lymphocytic leukemia (ALL), Hodgkin's lymphoma, certain brain tumours, and other types of cancer.[2] It is in a class of drugs known as podophyllotoxin derivatives and slows the growth of cancer cells in the body.[3] Contents 1 Medical uses 1.1 Administration 2 Contraindications 3 Side effects 4 Interactions 5 Pharmacology 5.1 Mechani... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Vumon 10 mg/ml Intravenous Injection, Solution

NDC: 0015-3075

Labeler:

E.r. Squibb & Sons, L.L.C.